Nurse dies after using weight-loss drug tirzepatide

A 58-year-old nurse from North Lanarkshire, Scotland, has reportedly died after taking the weight-loss drug tirzepatide, which was recently approved for
use on the NHS.

Susan McGowan died from multiple organ failure, septic shock and pancreatitis, with the use of the Eli Lilly drug listed as a contributing factor on her death
certificate, according to the BBC.

She had taken two low-dose injections of tirzepatide, known by the brand name Mounjaro, over a two-week period before her death on 4 September. Her death is
thought to be the first in the U.K. officially linked to the drug.

McGowan, who had worked for over 30 years as a nurse at University Hospital Monklands in Airdrie, purchased a prescription for the drug through a registered
online pharmacy.

A few days after her second injection, McGowen began experiencing severe stomach pains and sickness. She went to A&E at Monklands – where her colleagues tried
to save her life.

Within days, her kidneys failed, and she fell into a coma as her other organs began to fail.